Blanket Purchase Agreement GS35F540GA-75F40123A00003
Award Date
2/23/23
Last Date to Order
2/14/28
Federal Agency
Food and Drug Administration
Awardee
Accenture Federal Services LLC
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture plc. The BPA, titled "Modernizing FDA Data and Analytics," has a total ceiling value of $500,000,000 and an ultimate completion date of August 26, 2029. The BPA is intended to provide the FDA with a wide range of IT, consulting, and technology services to support the agency's data and analytics...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC, a global professional services company. The BPA, valued at up to $90 million, is for the provision of scientific, program management, and informatics governance modernization support services to the FDA's Center for Drug Evaluation and Research (CDER). Specific task orders issued under the BPA include a $13.4 million firm fixed-price...
The Blanket Purchase Agreement (BPA) awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC provides a range of business transformation and process improvement services. The $332 million, single-award contract, which runs through March 2026, leverages the General Services Administration's Multiple Award Schedule (MAS) contract vehicle to efficiently deliver professional services in areas such as digital transformation, data analytics,...
The Blanket Purchase Agreement (BPA) awarded to Accenture Federal Services LLC by the Food and Drug Administration (FDA) is a single-award contract valued at up to $332,000,000 over its 6-year period of performance from October 2020 to September 2026. The contract was awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) federal acquisition vehicle and is designated as a non-set-aside. The purpose of this BPA is to provide the FDA's Business Transformation...
This Blanket Purchase Agreement (BPA) entitled "OSP Professional Analytical Services" was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the prime contractor Guidehouse Inc., doing business as Navigant. The multiple-award BPA has a potential value of $50,000,000.00 and is set to expire on February 14, 2028. The BPA was established under the Office of Strategic Programs (OSP) Professional Analytical Services Indefinite...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc. as a single-award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, the BPA aims to procure scientific services in support of EO 14042 as described in the contract description. The BPA establishes an indefinite delivery/indefinite quantity...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a total ceiling value of $90,000,000 and a period of performance through January 7, 2026. The BPA is intended to provide the FDA with "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" across a range of professional service areas. As a single-award BPA issued under...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) has awarded a $50 million single-award Blanket Purchase Agreement (BPA) contract to Eastern Research Group Inc. (ERG), a for-profit environmental and health consulting firm. The BPA, titled "OSP Professional Analytical Services" for Tier 1, will provide the FDA with a range of professional analytical services to support the agency's Office of Regulatory Affairs programs over a five-year period. The BPA...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor LMI Consulting, LLC, a for-profit limited liability company that provides management consulting services to government clients. The BPA, issued against the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle, has a total ceiling value of $149,000,000 and an ultimate completion date of March 26, 2028. The BPA covers a...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a ceiling value of $100,000,000 and a period of performance through July 31, 2027. The contract vehicle is the General Services Administration's (GSA) Multiple Award Schedule (MAS). The BPA contract is for Next Generation Regulatory Business Information...